Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor–Mutated Nonsquamous Non–Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study

Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor–Mutated Nonsquamous Non–Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study

Abstract BackgroundHealth care system–wide outcomes from routine treatment with erlotinib and gefitinib are incompletely understood. ObjectiveThe aim of the study is to describe the effectiveness of erlotinib and gefitinib during the first decade of their routine u...

Full description

Saved in:
Bibliographic Details
Main Authors: Phyu Sin Aye, Joanne Barnes, George Laking, Laird Cameron, Malcolm Anderson, Brendan Luey, Stephen Delany, Dean Harris, Blair McLaren, Elliott Brenman, Jayden Wong, Ross Lawrenson, Michael Arendse, Sandar Tin Tin, Mark Elwood, Philip Hope, Mark James McKeage
Format: Article
Language:English
Published: JMIR Publications 2025-03-01
Series:JMIR Cancer
Online Access:https://cancer.jmir.org/2025/1/e65118
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://cancer.jmir.org/2025/1/e65118

Similar Items